p-Toluenesulfonic acid monohydrate → 2-(1,3-benzoxazol-2-ylmethyl)-6-(morpholin-4-yl)pyrimidin-4(3H)-one

HRID 1890457Notes

Reaction equation

HRID 1890457 reaction equation
O.CC1C=CC(S(O)(=O)=O)=CC=1.O[C:14]1[CH:19]=[CH:18][CH:17]=[CH:16][C:15]=1[NH:20][C:21](=[O:36])[CH2:22][C:23]1[NH:24][C:25](=[O:35])[CH:26]=[C:27]([N:29]2[CH2:34][CH2:33][O:32][CH2:31][CH2:30]2)[N:28]=1>C1(C)C=CC=CC=1>[O:36]1[C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][C:15]=2[N:20]=[C:21]1[CH2:22][C:23]1[NH:24][C:25](=[O:35])[CH:26]=[C:27]([N:29]2[CH2:30][CH2:31][O:32][CH2:33][CH2:34]2)[N:28]=1

Participants

4

Conditions

Temperature
0 °C

Procedure

20 mg of 4-methylbenzenesulphonic acid hydrate are added to a solution of 200 mg of N-(2-hydroxyphenyl)-2-[4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetamide in 40 ml of toluene. The reaction mixture is brought to reflux overnight. After cooling to 0° C., the insoluble material formed is filtered off. The filtrate is concentrated to dryness under reduced pressure and the residue is then chromatographed on a silica gel column, eluent: CH2Cl2/MeOH: 98/02 then 90/10. 16 mg of 2-(1,3-benzoxazol-2-ylmethyl)-6-(morpholin-4-yl)pyrimidin-4(3H)-one are thus obtained in the form of a white solid, the characteristics of which are the following:

Workup

  1. temperatureto reflux overnight
  2. customthe insoluble material formed
  3. filtrationis filtered off
  4. concentrationThe filtrate is concentrated to dryness under reduced pressure
  5. customthe residue is then chromatographed on a silica gel column, eluent

Sources & evidence

ORD record
ord-395068a204e14b9bb8686ce22d11db7b
Source dataset
uspto-grants-2013_08
Patent number
US08507483B2

Reaction notes

Loading…